Contact: Tom Hughes
University of North Carolina School of Medicine
Caption: Dr. John Buse of the University of North Carolina at Chapel Hill is co-principal investigator of the study, which is a follow-up to the ACCORD trial.
Credit: UNC School of Medicine
Usage Restrictions: None
Related news release: Scientists awarded $2.4 million to study genetic variation in people with diabetes